MedPath

Follicular fluid and plasma derived exosomal DNA methylation in polycystic ovary syndrome

Active, not recruiting
Conditions
Polycystic ovary syndrome (PCOS) in infertile women who seeking infertility treatment with in vitro fertilization (IVF)
PCOS, DNA methylation, exosome, follicular fluid, epigenetics, CYP19A1
Registration Number
TCTR20230831001
Lead Sponsor
Program Management Unit for Human Resources & Institutional Development,Research and Innovation (PMU-B)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
20
Inclusion Criteria

1. Female age 18-42 year old
2. Diagnosed as PCOS according to International Evidence-Based Guideline for the Assessment and Management of Polycystic ovary syndrome 2018

Exclusion Criteria

1. Diagnosed as any cancer
2. Diagnosed as endometriosis
3. Diagnosed as PCOS mimicking diseases such as Cushing syndrome, Adult onset adrenal hyperplasia, thyroid disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DNA methylation level in follicular fluid exosome at the end of recruitment Methylation specific PCR
Secondary Outcome Measures
NameTimeMethod
DNA methylation level in cumulus cell at the end of recruitment Methylation specific PCR
© Copyright 2025. All Rights Reserved by MedPath